Background: In obesity, metabolic stress and inflammation in injured tissues could favour enhanced shedding of procoagulant microparticles (MPs). At sites of endothelium injury, the swift recruitment of procoagulant leukocyte-derived MPs enables the initiation of blood coagulation and thrombus growth. Objectives: In obese females, we sought to evaluate the impact of a very low-calorie diet (VLCD) on procoagulant MP levels, fibrinolytic status, inflammation and endothelium damage. Methods: Circulating biomarkers of vascular damage, fibrinolytic status, platelet activation and inflammation were measured before, 30 and 90 days after starting a short-term VLCD. MPs were measured by flow cytometry and capture assays. Their procoagulant potential was quantified using functional prothrombinase assays and their cellular origin were determined using flow cytometry (endothelium, platelet, leukocyte, lymphocyte and erythrocyte-derived MP) or capture assays. Results: A total of 24 obese females (39 ± 10 years) with a mean body mass index of 35 ± 4 kg m À2 were prospectively enroled. Procoagulant leukocyte-derived MPs were associated with the waist circumference at baseline (r ¼ 0.534; P ¼ 0.010) and at 90 days follow-up (r ¼ 0.487; P ¼ 0.021). At 90 days, weight reduction (À9.8%) was associated with a lowering of blood pressure, improvement of metabolic parameters and a significant reduction of plasminogen activator inhibitor-1 (PAI-1) (À38%), procoagulant platelet-derived MPs (À43%), leukocyte-derived MPs (À28%) and leptin (À32%) levels. Conclusion: In obese females, a short-term VLCD results in an overall improvement of the haemostatic balance characterized by the reduction of PAI-levels, diminished release of platelet and leukocyte-derived MPs and a reduction in leptin levels, an adipocyte-derived cytokine.
Introduction
Obesity is intimately linked to insulin resistance, type 2 diabetes, vascular inflammation and atherothrombosis. 1 Dysregulation of various protein secretions, such as leptin, tumour necrosis factor-a and plasminogen activator inhibitor-1 (PAI-1) by the adipocyte has been suggested to have a pivotal role in enhanced inflammation, vascular damage and subsequent thrombogenicity. 2 In obesity, a preliminary report by our group has suggested that metabolic and inflammatory-mediated tissue injury could favour the release of procoagulant microparticles (MPs). 3 Likewise, in the metabolic syndrome, platelet-derived MPs were found associated to the severity of the syndrome. 4 In the vessel, MPs increase the catalytic procoagulant surface relying on the essential presence of phosphatidylserine for optimal haemostatic response. At sites of endothelium injury, the swift recruitment of leukocyte-derived procoagulant MPs enables the concentration of tissue factor activity leading to blood coagulation and thrombus growth. 5 When generated at high levels, circulating MPs were demonstrated to be potent effectors in the development of atherothrombosis by supporting cellular cross-talk involved in vascular inflammation and tissue remodelling, endothelial dysfunction, leukocyte adhesion and monocyte diapedesis within the plaque. 5 Various pathways susceptible to metabolic stress and inflammation could contribute to MP release and thrombotic propensity in obesity. For instance, by releasing tumour necrosis factor-a, the adipocyte directly suppresses insulin signalling, induces insulin resistance and could promote the shedding of procoagulant MPs by endothelial cells or monocytes. Besides its role in the development of adipose tissue and in the control of adipocyte insulin signalling, elevated plasma levels of PAI-1 in obese individuals could also contribute to the disruption of the haemostatic balance by preventing efficient fibrinolysis. 6 Moreover, the demonstration of the reduction of PAI-1 or platelet-derived MPs plasma levels through weight loss paves the way to a possible therapeutic target for controlling cardiovascular morbidity in obese subjects. 7, 8 To further characterize the relationship between obesity and the thrombotic risk, we sought to evaluate the impact of a short-term very low-calorie diet (VLCD) on procoagulant MP levels, fibrinolytic status, inflammation and endothelium damage. Given the prime importance of leukocyte shedding in the formation of the thrombus, special attention was paid to the variation of leukocyte-derived MPs levels.
Subjects and methods

Subjects
The local medical ethics committee approved the study protocol and written informed consent was obtained from each subject according to the declaration of Helsinki. 9 Briefly, platelet-free plasma was obtained after an initial centrifugation at 1500 g for15 min followed by a 2 min centrifugation at 13 000 g and was aliquoted and frozen (À80 1C) until required for analysis.
Isolation of circulating MPs, determination of their cellular origin and functional assessment of their procoagulant activity MPs were isolated either by capture on insolubilised annexin-5 or using specific antibodies. Both ligands (antibodies or annexin-5) were separately insolubilised onto streptavidin-coated microtitration plates before incubation with platelet-poor-plasma. Biotinylated annexin-5 has a strong affinity for procoagulant phosphatidylserine accessible at the MP surface. As phosphatidylserine is a ubiquitous feature of procoagulant MPs, it provides information on the total amount of circulating procoagulant MPs, regardless of their cellular origin. The quantity of MPs captured onto biotinylated monoclonal antibodies gives an additional indication of their cellular origin and the cellular response to vascular stress. In the present study, the following biotinylated monoclonal antibodies were used: CD11a (leukocytes), CD31 (endothelial cells and platelets) and GPIb (platelets). During MP quantitation, the background reactivities to isotypic irrelevant IgG were subtracted from all values.
After platelet-poor-plasma incubation and the washing steps, annexin-5 and antibody-captured procoagulant MPs were quantified using a functional prothrombinase assay. This assay measures the procoagulant phosphatidylserine content of MPs through its ability to promote the activation of prothrombin to thrombin in a calibrated purified system ensuring that phosphatidylserine is the rate-limiting 
Miscellaneous measurements
Quantitative determination of plasma von Willebrand factor antigen was performed using immunoturbidimetric assays. PAI-1 plasma concentrations were determined using a synthetic chromogenic substrate method.
Statistical analysis
Categorical data are described with number and proportion of subject in each category. Continuous data are described using mean and standard error. Parametric Pearson's or nonparametric Spearman's correlation coefficient were computed. Repeated data were analysed using mixed models. For each model, three variances-covariances were fitted: unstructured, heterogeneous compound symetry and heterogeneous Toeplitz. The choice of the best fitting matrix among the three types was based on the AIC. Significance level was set to 0.05. Computation was done with SPSS 13.0 (SPSS Inc., Chicago, IL, USA).
Results
Detailed characteristics of the 24 obese female subjects and variations of anthropometrics and biological parameters between D0, D30 and D90 are given in Tables 1 and 2 . At baseline, the mean BMI and mean waist circumference were 35±4 kg m À2 and 101±11 cm, respectively. Leptin levels were related to weight (r ¼ 0.470; P ¼ 0.020), BMI (r ¼ 0.472; P ¼ 0.020), fat mass (r ¼ 0.433; P ¼ 0.033) and vWF levels, a marker of endothelium damage (r ¼ 0.440; P ¼ 0.031). Procoagulant leukocyte-derived MPs were associated with waist circumference at baseline (r ¼ 0.534; P ¼ 0.010) and at D30 (r ¼ 0.679; P ¼ 0.001) and at D90 (r ¼ 0.487; P ¼ 0.021) followup ( Figure 1 ).
Consequences of VLCD on clinical and biological parameters
After 90 days of VLCD, a significant body weight loss was observed (À9.8%; Po0.001). Similarly, waist circumference, blood pressure, total cholesterol and triglycerides, fasting plasma glucose, fasting plasma insulin and the homeostasis model assessment index were significantly decreased at D30 and D90 (Table 1) .
Consequences of a short-term VLCD on haemostatic and inflammation parameters Short-term VLCD induced a significant reduction in PAI-1 (À38%), procoagulant-platelet derived MPs (À43%) and leptin levels (À32%). Consistent with a diminished
Microparticles and weight loss O Morel et al leukocyte/lymphocyte activation, lower levels of leukocytederived MPs and lymphocyte-derived MPs were evidenced at D30 or D90 ( Table 2) . Variations of leptin levels between D0 and D90 were significantly correlated with weight loss (r ¼ 0.648; P ¼ 0.001) (Figure 2 ). Variations of PAI-1 levels between D0 and D90 were significantly correlated with homeostasis model assessment variations (r ¼ 0.590; P ¼ 0.003). Conversely, variations in erythrocyte and endothelialderived MP, endothelium damage marker (CD235 þ -MPs, CD62 þ -MPs, vWF), pro-inflammatory cytokines (tumour necrosis factor-a, interleukin-6) levels did not reach statistical significance.
Discussion
In the present study, we have shown that a short-term VLCD in obese females induces a significant reduction in PAI-1, in procoagulant platelet and leukocyte-derived MPs and in leptin levels. Our data suggest that weight reduction may Microparticles and weight loss O Morel et al contribute to the restoration of the haemostatic balance through fibrinolysis improvement and the reduction of: (i) adipocyte-mediated inflammation (ii) platelet and leukocyte activation. Given the prime importance of leukocytederived MPs in the formation of arterial or venous thrombus, it is likely that the lowering of leukocyte activation favourably affects the thrombotic propensity described in obesity.
Obesity associated inflammation and vascular damage
At baseline, the correlation between leptin levels, anthropometric parameters (weight, BMI and fat mass) or vWF, a marker of endothelium damage, is consistent with an inflammatory pathogenic pathway mediated by adipocytes. Leptin, a glycoprotein produced by mature adipocytes, resembles, both structurally and functionally, the proinflammatory cytokines such as interleukin-6 and may modulate C-reactive protein. Increased circulating leptin levels, a marker of leptin resistance, is common in obesity and independently associated with atherosclerotic burden in humans. 11 In a large cohort of healthy individuals, independently of established cardiovascular risk factors, a positive relationship between coronary calcification and leptin levels has recently been reported. 12 Indeed, besides its key role in the regulation of body fat stores, several reports have indicated that leptin may directly promote atherothrombosis through the enhancement of inflammatory pathways or induced platelet aggregation. Recent evidence suggests that leptin induces C-reactive protein expression in human coronary artery endothelial cells, 13 promotes intimal monocyte recruitment 14 and elicits macrophage foam cell formation. 15 During weight loss, as observed in the present study, leptin plasma levels decrease (Figure 2 ). Our report of a relationship between leptin and vWF levels could reinforce the view that leptin-mediated inflammation is associated with endothelial dysfunction and subsequent atherosclerosis. Consistent with a direct role of leptin in thrombosis, experimental studies have shown that ob/ob mice that are defective in leptin secretion, show impaired thrombus formation in response to vascular injury that is subsequently restored by leptin administration. [16] [17] [18] However, in the present study, the lack of robust correlation between leptin and platelet-MPs, a reliable marker of platelet activation, did not substantiate the view that leptin directly modulates platelet activation, even though leptin binding to its platelet receptor promotes aggregation. [16] [17] [18] Leukocyte-derived MPs could be key factors in pathways activated by obesity-mediated inflammation. In the present study, leukocyte-derived MPs were the sole parameter associated with waist circumference at baseline and at follow-up (Figure 1 ). Interestingly, a significant reduction in leukocyte and lymphocyte-derived MPs could be observed after weight loss (Table 2) . Leukocyte-derived MPs were demonstrated to induce endothelial dysfunction, to favour the secretion of pro-inflammatory cytokines by activated endothelial cells and to promote the expression of tissue factor, the main initiator of blood coagulation. 5 Notably, in healthy individuals, leukocyte-derived MPs were found to be associated with the component of metabolic syndrome or the Framingham risk score and were predictive of the extent of infra-clinical atheroma independently of traditional risk factors. 19 With respect to the current knowledge, we believed that the demonstration of the reduction of leukocytesderived MPs is potentially meaningful on a pathophysiological point of view. Indeed, when considering the intricate mechanisms of thrombosis, several lines of evidences pointed at a key role for leukocyte-derived MPs. Using Procoagulant Leukocytes-derived MPs 3.00 4.00 5.00 Figure 1 Correlation between waist circumference and procoagulant leukocyte-derived MPs at baseline. Procoagulant MPs were captured onto insolubilised CD11a antibody and their procoagulant potential was assessed by functional prothrombinase assay as nanomolar phosphatidylserine equivalents (nM PhtSer Eq). Correlation was computed using a non-parametric Spearman's correlation coefficient.
Microparticles and weight loss O Morel et al intravital real-time microscopy to monitor the thrombus growth at sites of vessel injury, several groups have established that the swift recruitment at the edge of the thrombus of leukocytes and leukocytes-derived MPs through P-selection/P-selectin glycoprotein ligand-1 interactions are mandatory for the development of the thrombus. 20 In another experimental mouse model of venous thrombosis, leukocyte-derived MPs levels were negatively correlated with the thrombus weight suggesting their early incorporation within the growing thrombus. In addition, MPs reinjection led to greater thrombus weight. 21 Conversely, plateletsderived MPs were positively correlated with the thrombus growth. 21 It is thus likely that the accumulation of leukocyte-derived MPs harbouring TF activities is mandatory for the onset of thrombosis, whereas the levels of plateletsderived MPs mostly testify the extent of platelet stimulation. Likewise, in the setting of acute myocardial infarction, we have previously demonstrated the importance of inflammatory cells trapping together with the shedding of leukocytesderived MPs harbouring TF activities in thrombus formation.
In this work, in accordance with the latter paradigm, with respect to the eventual role played by platelet-derived MPs, leukocyte-derived MPs appear to be the main contributor of TF activities at the vicinity of the arterial thrombus. 22 Altogether, these data underline the prime importance of the recruitment leukocyte-derived MPs in the concentration of TF activity at site of endothelium injury.
Consequences of weight reduction on platelet activation
In our study, at baseline, higher levels of procoagulant platelet-derived MPs were observed in insulin resistant obese females (data not shown). Previous studies have suggested that insulin resistance, a common feature in obesity or metabolic syndrome, could be directly implicated in platelet stimulation. 23 The possible mechanisms involved in platelet stimulation in obesity are related to: (i) the reduced sensitivity to insulin and other substances acting through intracellular cyclic nucleotides, such as nitrates and prostacyclin; (ii) the rise of cytosolic (Ca 2 þ ); and (iii) the increased oxidative stress, which elicits isoprostane production from arachidonic acid. 24 The administration of insulin inhibits platelet interaction with collagen under conditions mimicking thrombus formation and reduces healthy platelet aggregation in response to several platelets agonists whereas insulin was found to be inefficient in obese, insulin resistant patients. 25 Very recently, Russo et al. 26 have demonstrated that diet-induced weight loss reduces platelet activation and restores the sensitivity to the physiological anti-aggregating agents. In the present study, the drastic 43% reduction in platelet-derived procoagulant MP levels, a reliable marker of platelet stimulation, obtained after VLCD confirms the hypothesis that weight loss had a direct protective effect on platelet stimulation. Consequences of weight reduction on fibrinolysis balance In our study, baseline PAI-1 levels were higher in obese females with metabolic syndrome (data not shown). In adipose tissue from obese mice and humans, PAI-1 expression has been reported to be upregulated, thereby increasing plasma PAI-1 levels. In humans, increased PAI-1 expression is associated with insulin resistance identified by visceral fat accumulation. 6 PAI-1, by neutralising tissue-type plasminogen activator, inhibits fibrinolysis and protects clots from early lysis. Accordingly, during myocardial infarction, the acute release of PAI-1 was found to be an independent predictor of 30 days mortality. 28 In the past, prospective cohort studies conducted in atherosclerotic patients have indicated that elevated PAI-1 plasma concentrations are associated with adverse cardiovascular outcome. [29] [30] [31] In dietinduced type 2 diabetic mice, both the intensity of macrophage infiltration and impaired fibrinolysis, as reflected by the measurement of the uPA/PAI-1 ratio, were found to be involved in impaired resolution of deep vein thrombosis. 32 In the present study, VLCD induces a 38% reduction in PAI-levels, a result in line with previously published data. 33 As adipocytes represent an important source of PAI-1 synthesis, changes in PAI-1 levels are commonly purported to mainly reflect weight loss rather than a diminished insulin resistance. However, in the present work, PAI-1 decrease was only related to homeostasis model assessment variation, suggesting a direct impact of insulinemia on PAI-1 synthesis. Using cell culture models, previous reports have suggested that various inducers like triglycerides, free fatty acids, angiotensin II, or high doses of insulin could target the upregulation of PAI-1 synthesis in insulin resistant patients. 34 Although the plasminogen counterpart was not assessed in the present study, our data suggest that weight reduction results in an overall improvement of the fibrinolytic balance.
Other mechanisms potentially involved in the reduction of MPs levels In the present study, no definite conclusion concerning putative mechanisms possibly contributing to the lowering of circulating levels of MPs (reduced generation of MPs,
Microparticles and weight loss O Morel et al accelerated clearance) could be raised. Although leukocytederived MPs were found to be correlated with waist circumference at baseline, at D30 and at D90, no correlation between leukocyte-derived MPs or platelet-derived MPs and the variation of the lipidic status or weight reduction could be evidenced. However, we could not exclude that the diet-reduction on cholesterol and triglycerides levels or the lowering of arterial hypertension may contribute to a diminished release of MPs. In the literature, several papers have emphasised that the ingestion of typical western diet could contribute to the shedding of endothelial-derived MPs, [35] [36] [37] or associated tissue factor activity 38 whereas the impact of fat ingestion on leukocyte-derived MPs levels is up to now not characterized. In addition, we could not exclude that the lowering of blood pressure could contribute to reduce platelet shedding through decrease shear stress. 39, 40 In the present study, because various agonists are likely to contribute to MPs shedding in the vasculature, we could not decipher the respective contribution of: (i) lipid lowering, (ii) weight reduction, (iii) inflammatory status reduction, (iv) lowering of blood pressure in the reduction of MPs levels. Altogether, our data show that short-term VLCD leads to an improvement of the haemostatic balance through the modulation of adipocyte-induced inflammation, fibrinolysis, platelet and leukocyte activation. Albeit outside the scope of this study, given the prime importance of leukocytederived MPs in thrombotic process, it is tempting to speculate that the overall improvement of the haemostatic status brought about by weight reduction could have a favourable impact on cardiovascular outcome in obese patients.
Conclusion
In obese females, a VLCD results in an overall improvement of the haemostatic balance characterized by the reduction of PAI-levels, a fibrinolysis inhibitor, diminished platelet and leukocyte release of procoagulant MPs and a reduction in levels of the adipocyte-derived cytokine, leptin. Given the prime importance of leukocyte-derived MPs in the formation of arterial or venous thrombus, it is likely that the lowering of leukocyte activation favourably affects the thrombotic propensity described in obesity.
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